SCHEMBL23584601

SCHEMBL23584601

CCN1CCC2(CC1)CC(F)(F)CN2C[C@@H]1CC[C@H](c2ccc3c(N)ncnn23)O1

nearest known ligand 0.37

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ PRMT5 O14744 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22434978 0.91 PRMT5 (0.38) PRMT5
SCHEMBL23584466 0.90 PRMT5 (0.36) PRMT5
SCHEMBL22435029 0.89 PRMT5 (0.36) PRMT5
SCHEMBL23584605 0.88 PRMT5 (0.30) PRMT5
SCHEMBL23584538 0.87 PRMT5 (0.35) PRMT5
SCHEMBL22435009 0.87 PRMT5 (0.49) PRMT5
SCHEMBL23584799 0.87 PRMT5 (0.38) PRMT5
SCHEMBL19344174 0.84 POLRMT (0.32) PRMT5
SCHEMBL22434806 0.83 CNR2 (0.37) PRMT5
SCHEMBL23584795 0.83 CNR2 (0.37) PRMT5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3426664-B1 SUBSTITUTED NUCLEOSIDE ANALOGUES FOR USE AS PRMT5 INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2021-06-30 — — EP disclosed
Send feedback